{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:39:28Z","timestamp":1787009968656,"version":"build-2736575974"},"reference-count":51,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2012,10]]},"DOI":"10.1097\/ftd.0b013e31826517c6","type":"journal-article","created":{"date-parts":[[2012,9,11]],"date-time":"2012-09-11T20:37:12Z","timestamp":1347395832000},"page":"518-525","source":"Crossref","is-referenced-by-count":45,"title":["Association Between Lamotrigine Concentrations and ABCB1 Polymorphisms in Patients With Epilepsy"],"prefix":"10.1097","volume":"34","author":[{"given":"Mila","family":"Lovri\u0107","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada","family":"Bo\u017eina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanja","family":"Hajn\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina Rojni\u0107","family":"Kuzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davor","family":"Spori\u0161","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenka","family":"Lali\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Bo\u017eina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Grani\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-7-20210129","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1093\/brain\/awh726","article-title":"Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study.","volume":"129","author":"Sillanpa","year":"2006","journal-title":"Brain"},{"key":"R2-7-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.2009.225","article-title":". Transporters in drug-refractory epilepsy: clinical significance.","volume":"87","author":"Marchi","year":"2010","journal-title":"Clinic Pharmacol Ther"},{"key":"R3-7-20210129","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/clpt.2009.237","article-title":"ABC transporters in drug-refractory epilepsy: limited clinical significance of pharmacogenetics.","volume":"87","author":"Cascorbi","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R4-7-20210129","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.1046\/j.1528-1157.2001.12301.x","article-title":". Overexpression of multiple drug resistance genes in endothelial cells from patients with refractory epilepsy.","volume":"42","author":"Dombrowski","year":"2001","journal-title":"Epilepsia"},{"key":"R5-7-20210129","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1111\/j.0013-9580.2005.31904.x","article-title":"Potential role of drug transporters in the pathogenesis of medically intractable epilepsy.","volume":"46","author":"Kwan","year":"2005","journal-title":"Epilepsia"},{"key":"R6-7-20210129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1101\/gr.1965304","article-title":". Identifying Candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene.","volume":"14","author":"Soranzo","year":"2004","journal-title":"Genome Res"},{"key":"R7-7-20210129","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1056\/NEJMoa021986","article-title":". Association of multidrug resistance in epilepsy with a polymorphism in the drug-transporter gene ABCB1.","volume":"348","author":"Siddiqui","year":"2003","journal-title":"N Engl J Med"},{"key":"R8-7-20210129","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1097\/FTD.0b013e318067ce90","article-title":"Therapeutic drug monitoring and clinical outcomes in epileptic Egyptian patients: a gene polymorphism perspective study.","volume":"29","author":"Ebid","year":"2007","journal-title":"Ther Drug Monit"},{"key":"R9-7-20210129","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1528-1167.2005.46304.x","article-title":". Lack of association between the C3435T polymorphism in the human multidrug resistance (MDR1) gene and response to antiepileptic drug treatment.","volume":"46","author":"Sills","year":"2005","journal-title":"Epilepsia"},{"key":"R10-7-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.eplepsyres.2006.10.004","article-title":". The controversial association of ABCB1 polymorphisms in refractory epilepsy: an analysis of multiple SNPs in Irish population.","volume":"73","author":"Shahwan","year":"2007","journal-title":"Epilepsy Res"},{"key":"R11-7-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci Lett"},{"key":"R12-7-20210129","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1080\/00498250701867889","article-title":"Structure, function and regulation of P-glycoprotein and its clinical relevance in drug disposition.","volume":"38","author":"Zhou","year":"2008","journal-title":"Xenobiotica"},{"key":"R13-7-20210129","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.pharmthera.2006.04.009","article-title":"Role of pharmacogenetics of ATP-binding cassette transporters in the pharmacokinetics of drugs.","volume":"112","author":"Cascorbi","year":"2006","journal-title":"Pharmacol Ther"},{"key":"R14-7-20210129","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1097\/FPC.0b013e3283385a1c","article-title":". Very important pharmacogene summary: ABCB1 (MDR1, P-glycoprotein).","volume":"21","author":"Hodges","year":"2011","journal-title":"Pharmacogenet Genom"},{"key":"R15-7-20210129","doi-asserted-by":"crossref","first-page":"3473","DOI":"10.1073\/pnas.97.7.3473","article-title":". Functional polymorphisms of the human multidrug-resistance gene: multiple sequence variations and correlation of one allele with P-glycoprotein expression and activity in vivo.","volume":"97","author":"Hoffmeyer","year":"2000","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R16-7-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.clpt.2003.09.012","article-title":". Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance.","volume":"75","author":"Marzolini","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R17-7-20210129","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1097\/00007691-200404000-00017","article-title":"Clinical aspects of the MDR1 (ABCB1) gene polymorphism.","volume":"26","author":"Eichelbaum","year":"2004","journal-title":"Ther Drug Monit"},{"key":"R18-7-20210129","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.clpt.2004.04.011","article-title":". Carbamazepine regulates intestinal P-glycoprotein and multidrug resistance protein MRP2 and influences disposition of talinolol in humans.","volume":"76","author":"Giessmann","year":"2004","journal-title":"Clin Pharmacol Ther"},{"key":"R19-7-20210129","doi-asserted-by":"crossref","first-page":"553","DOI":"10.2165\/00003088-200443090-00001","article-title":"The MDR1 (ABCB1) gene polymorphism and its clinical implications.","volume":"43","author":"Ieiri","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"R20-7-20210129","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1124\/jpet.301.1.7","article-title":"Role of multidrug transporters in pharmacoresistance to antiepileptic drugs.","volume":"301","author":"Loscher","year":"2002","journal-title":"J Pharmacol Exp Ther"},{"key":"R21-7-20210129","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1046\/j.1365-2125.1998.00835.x","article-title":". Lamotrigine and therapeutic drug monitoring: retrospective survey following the introduction of a routine service.","volume":"46","author":"Morris","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"R22-7-20210129","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00228-006-0144-9","article-title":". Lamotrigine pharmacokinetic evaluation in epileptic patients submitted to VEEG monitoring.","volume":"62","author":"Almeida","year":"2006","journal-title":"Eur J Clin Pharmacol"},{"key":"R23-7-20210129","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1515\/CCLM.2004.245","article-title":". Therapeutic drug monitoring of old and newer anti-epileptic drugs.","volume":"42","author":"Neels","year":"2004","journal-title":"Clin Chem Lab Med"},{"key":"R24-7-20210129","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2165\/00003088-200645110-00002","article-title":"Pharmacokinetic variability of newer antiepileptic drugs.","volume":"45","author":"Johannessen","year":"2006","journal-title":"When is monitoring needed Clin Pharmacokinet"},{"key":"R25-7-20210129","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1093\/nar\/16.3.1215","article-title":"A simple salting out procedure for extracting DNA from human nucleated cell.","volume":"16","author":"Miller","year":"1988","journal-title":"Nucl Acid Res"},{"key":"R26-7-20210129","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.ab.2004.07.030","article-title":". Genotyping of the triallelic variant G2677TA in MDR1 using LightCycler with locked-nucleic-acid-modified hybridization probes.","volume":"334","author":"Arjomand-Nahad","year":"2004","journal-title":"Anal Biochem"},{"key":"R27-7-20210129","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1472-8206.2003.00163.x","article-title":". MDR1 polymorphisms G2677T in exon 21 and C3435T in exon 26 fail to affect rhodamine 123 efflux in peripheral blood lymphocytes.","volume":"17","author":"Oselin","year":"2003","journal-title":"Fundam Clin Pharmacol"},{"key":"R28-7-20210129","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1093\/clinchem\/47.6.1048","article-title":". No influence of the MDR-1 C3435T polymorphism or a CYP3A4 promoter polymorphism (CYP3A4-V allele) on dose-adjusted cyclosporin A trough concentrations or rejection incidence in stable renal transplant recipients.","volume":"47","author":"von Ahsen","year":"2001","journal-title":"Clin Chem"},{"key":"R29-7-20210129","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2307\/2532296","article-title":"Performing the exact test of Hardy-Weinberg proportions for multiple alleles.","volume":"48","author":"Guo","year":"1992","journal-title":"Biometrics"},{"key":"R30-7-20210129","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/hdy.1996.55","article-title":"Testing for linkage disequilibrium in genotypic data using the EM algorithm.","volume":"76","author":"Slatkin","year":"1996","journal-title":"Heredity"},{"key":"R33-7-20210129","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/j.1558-5646.1989.tb04220.x","article-title":"Analyzing tables of statistical tests.","volume":"43","author":"Rice","year":"1989","journal-title":"Evolution"},{"key":"R34-7-20210129","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.1528-1167.2006.00414.x","article-title":". Influence of lamotrigine and topiramate on MDR1 expression in difficult-to-treat temporal lobe epilepsy.","volume":"47","author":"Wang-Tilz","year":"2006","journal-title":"Epilepsia"},{"key":"R35-7-20210129","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.yebeh.2007.04.013","article-title":". Association between ABCB1 C3435T polymorphism and drug-resistant epilepsy in Han Chinese.","volume":"11","author":"Kwan","year":"2007","journal-title":"Epilepsy Behav"},{"key":"R36-7-20210129","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1517\/14622416.6.4.411","article-title":". Complex haplotypic effects of the ABCB1 gene on epilepsy treatment response.","volume":"6","author":"Hung","year":"2005","journal-title":"Pharmacogenomics"},{"key":"R37-7-20210129","doi-asserted-by":"crossref","first-page":"551","DOI":"10.2217\/14622416.7.4.551","article-title":". ABCB1 polymorphisms influence the response to antiepileptic drugs in Japanese epilepsy patients.","volume":"7","author":"Seo","year":"2006","journal-title":"Pharmacogenomics"},{"key":"R38-7-20210129","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1212\/01.WNL.0000141021.42763.F6","article-title":". Association of an ABCB1 gene haplotype with pharmacoresistance in temporal lobe epilepsy.","volume":"63","author":"Zimprich","year":"2006","journal-title":"Neurology"},{"key":"R39-7-20210129","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1124\/jpet.103.054197","article-title":". Interaction of antiepileptic drugs with human P-Glycoprotein in vitro.","volume":"307","author":"Weiss","year":"2003","journal-title":"J Pharmacol Exp Ther"},{"key":"R40-7-20210129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0304-3940(02)00423-8","article-title":"P-Glycoprotein-mediated efflux of phenobarbital, lamotrigine, and felbamate at the blood-brain barrier: evidence from microdialysis experiments in rats.","volume":"327","author":"Potschka","year":"2002","journal-title":"Neurosci Lett"},{"key":"R41-7-20210129","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1111\/j.0013-9580.2003.22603.x","article-title":"Brain access and anticonvulsant efficacy of carbamazepine, lamotrigine, and felbamate in ABCC2MRP2-deficient TR- rats.","volume":"44","author":"Potschka","year":"2003","journal-title":"Epilepsia"},{"key":"R42-7-20210129","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.neuropharm.2006.07.038","article-title":". Differences in the transport of the antiepileptic drugs phenytoin, levetiracetam and carbamazepine by human mouse P-glycoprotein.","volume":"52","author":"Balts","year":"2007","journal-title":"Neuropharmacology"},{"key":"R43-7-20210129","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/j.seizure.2008.01.003","article-title":". The influence of C3435T polymorphism of ABCB1 gene on penetration of phenobarbital across the blood-brain barrier in patients with generalized epilepsy.","volume":"17","author":"Basic","year":"2008","journal-title":"Seizure"},{"key":"R44-7-20210129","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1111\/j.1528-1167.2008.01561.x","article-title":". Antiepileptic drugsbest practice guidelines for therapeutic drug monitoring: a position paper by the Subcommission on Therapeutic Drug Monitoring, ILAE Commission on Therapeutic Strategies.","volume":"49","author":"Patsalos","year":"2008","journal-title":"Epilepsia"},{"key":"R45-7-20210129","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.phrs.2008.09.010","article-title":"Citalopram enantiomers in plasma and cerebrospinal fluid of ABCB1 genotyped depressive patients and clinical response: a pilot study.","volume":"58","author":"Nikisch","year":"2008","journal-title":"Pharmacol Res"},{"key":"R46-7-20210129","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1101\/gr.1965304","article-title":". Identifying Candidate causal variants responsible for altered activity of the abcb1 multidrug resistance gene.","volume":"14","author":"Soranzo","year":"2004","journal-title":"Genome Res"},{"key":"R47-7-20210129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1126\/science.1135308","article-title":". A silent polymorphism in the MDR1 gene changes substrate specificity.","volume":"26","author":"Kimchi-Sarfaty","year":"2007","journal-title":"Science"},{"key":"R48-7-20210129","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.eplepsyres.2008.12.001","article-title":". Lack of association between ABCB1, ABCG2, and ABCC2 genetic polymorphisms and multidrug resistance in partial epilepsy.","volume":"84","author":"Kim","year":"2009","journal-title":"Epilepsy Res"},{"key":"R50-7-20210129","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/clpt.2009.225","article-title":". Transporters in drug-refractory epilepsy: clinical significance.","volume":"87","author":"Marchi","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"R51-7-20210129","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.pharmthera.2009.10.004","article-title":"Targeting regulation of ABC efflux transporters in brain diseases: a novel therapeutic approach.","volume":"125","author":"Potschka","year":"2010","journal-title":"Pharmacol Ther"},{"key":"R52-7-20210129","first-page":"1333","article-title":"Modulating P-glycoprotein regulation: future perspectives for pharmacoresistant epilepsies Epilepsia.","volume":"51","author":"Potschka","year":"2010","journal-title":""},{"key":"R53-7-20210129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.eplepsyres.2011.01.016","article-title":". The relationship between UGT1A4 polymorphism and serum concentration of lamotrigine in patients with epilepsy.","volume":"95","author":"Gulcebi","year":"2011","journal-title":"Epilepsy Res"},{"key":"R54-7-20210129","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1097\/FTD.0b013e3181ceecc6","article-title":". UGT2B7-161CT polymorphism is associated with lamotrigine concentration-to-dose ratio in a multivariate study.","volume":"32","author":"Blanca Sanchez","year":"2010","journal-title":"Ther Drug Monit"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/FTD.0b013e31826517c6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,13]],"date-time":"2021-05-13T20:39:55Z","timestamp":1620938395000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201210000-00007"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,10]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0b013e31826517c6","relation":{},"ISSN":["0163-4356"],"issn-type":[{"value":"0163-4356","type":"print"}],"subject":[],"published":{"date-parts":[[2012,10]]}}}